208 related articles for article (PubMed ID: 9122710)
1. Coreceptors: implications for HIV pathogenesis and therapy.
Moore JP
Science; 1997 Apr; 276(5309):51-2. PubMed ID: 9122710
[No Abstract] [Full Text] [Related]
2. Chemokine inhibitors for HIV.
Eccleston A
Nat Biotechnol; 1997 Aug; 15(8):709, 710. PubMed ID: 9255775
[No Abstract] [Full Text] [Related]
3. HIV-1--co-receptors binding.
Jiang S
Nat Med; 1997 Apr; 3(4):367-8. PubMed ID: 9095160
[No Abstract] [Full Text] [Related]
4. Exploiting the HIV-chemokine nexus.
Cohen J
Science; 1997 Feb; 275(5304):1261-4. PubMed ID: 9064780
[No Abstract] [Full Text] [Related]
5. A second coreceptor for HIV in early stages of infection.
Balter M
Science; 1996 Jun; 272(5269):1740. PubMed ID: 8650568
[No Abstract] [Full Text] [Related]
6. HIV-1 tropism and co-receptor use.
Dittmar MT; McKnight A; Simmons G; Clapham PR; Weiss RA; Simmonds P
Nature; 1997 Feb; 385(6616):495-6. PubMed ID: 9020356
[No Abstract] [Full Text] [Related]
7. Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives.
Utaipat U; Duerr A; Rudolph DL; Yang C; Butera ST; Lupo D; Pisell T; Tangmunkongvorakul A; Kamtorn N; Nantachit N; Nagachinta T; Suriyanon V; Robison V; Nelson KE; Sittisombut N; Lal RB
AIDS Res Hum Retroviruses; 2002 Jan; 18(1):1-11. PubMed ID: 11804551
[TBL] [Abstract][Full Text] [Related]
8. Expression pattern of HIV-1 coreceptors on T cells: implications for viral transmission and lymphocyte homing.
Unutmaz D; Littman DR
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1615-8. PubMed ID: 9050826
[No Abstract] [Full Text] [Related]
9. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop.
Speck RF; Wehrly K; Platt EJ; Atchison RE; Charo IF; Kabat D; Chesebro B; Goldsmith MA
J Virol; 1997 Sep; 71(9):7136-9. PubMed ID: 9261451
[TBL] [Abstract][Full Text] [Related]
10. AIDS: the process of discovery.
Varmus H; Paul W
Science; 1997 Jan; 275(5297):141; author reply 142. PubMed ID: 8999539
[No Abstract] [Full Text] [Related]
11. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry.
Simmons G; Wilkinson D; Reeves JD; Dittmar MT; Beddows S; Weber J; Carnegie G; Desselberger U; Gray PW; Weiss RA; Clapham PR
J Virol; 1996 Dec; 70(12):8355-60. PubMed ID: 8970955
[TBL] [Abstract][Full Text] [Related]
12. HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors.
Zaitseva M; Peden K; Golding H
Biochim Biophys Acta; 2003 Jul; 1614(1):51-61. PubMed ID: 12873765
[TBL] [Abstract][Full Text] [Related]
13. Investigators detail HIV's fatal handshake.
Cohen J
Science; 1996 Oct; 274(5287):502. PubMed ID: 8928003
[No Abstract] [Full Text] [Related]
14. The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells.
Arthos J; Cicala C; Selig SM; White AA; Ravindranath HM; Van Ryk D; Steenbeke TD; Machado E; Khazanie P; Hanback MS; Hanback DB; Rabin RL; Fauci AS
Virology; 2002 Jan; 292(1):98-106. PubMed ID: 11878912
[TBL] [Abstract][Full Text] [Related]
15. Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry.
Doms RW; Peiper SC
Virology; 1997 Sep; 235(2):179-90. PubMed ID: 9281497
[No Abstract] [Full Text] [Related]
16. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
[TBL] [Abstract][Full Text] [Related]
17. Position 22 of the V3 loop is associated with HIV infectivity.
Wei XM; Xu HF; Cheng XD; Bu N; Zhou HZ
Arch Virol; 2017 Mar; 162(3):637-643. PubMed ID: 27815696
[TBL] [Abstract][Full Text] [Related]
18. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.
Bleul CC; Wu L; Hoxie JA; Springer TA; Mackay CR
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1925-30. PubMed ID: 9050881
[TBL] [Abstract][Full Text] [Related]
19. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.
Simmons G; Clapham PR; Picard L; Offord RE; Rosenkilde MM; Schwartz TW; Buser R; Wells TN; Proudfoot AE
Science; 1997 Apr; 276(5310):276-9. PubMed ID: 9092481
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 subtype and second-receptor use.
Zhang L; Huang Y; He T; Cao Y; Ho DD
Nature; 1996 Oct; 383(6603):768. PubMed ID: 8892998
[No Abstract] [Full Text] [Related]
[Next] [New Search]
